%PDF-1.3
%
4 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xA0}O1K]G5 z"%>)nf{Z;Uƅˠn*jZI^ n#-!1ʄ}ܖOf]]ǘN"W]zT
\2ko'n
endstream
endobj
11 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2021-11-03T10:24:45-07:00
2020-12-14T09:14:50+05:30
application/pdf
CAN-2019-0079-ver9-Gazendam_3P 290..297
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:dc1fea4f-bfed-458f-9e7f-f4f12c39c83c
uuid:640be3fd-2557-4a5a-974d-765f2fc84b28
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
29 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
10.959 0 0 10.959 59.7543 697.8896 Tm
0 0 0 rg
0 Tc
0 Tw
[(and)-338.5(no)-335.1(meta-analyses)-335.4(investigating)-333.5(the)-339.2(effects)-333.8(of)-336.8(can-)]TJ
0 -1.1847 TD
[(nabinoids)-231.1(in)-228.5(the)-225.4(clinical)-227.4(setting)-228.1(for)-231.4(acute)-226.6(pain.)]TJ
8.2191 0 0 7.3052 259.9369 689.7825 Tm
(7)Tj
10.959 0 0 10.959 266.3999 684.9069 Tm
(Stevens)Tj
-18.8562 -1.1795 TD
[(and)-281.6(Higgins)-271.9(concluded)-277.6(that,)-279.3()47.3(on)-277.4(the)-277.1(basis)-273.6(of)-279.9(the)-277.1(avail-)]TJ
0 -1.1847 TD
[(able)-523.2(randomized)-521.7(controlled)-524.5(trial)-518.4(evidence,)-524.1(cannabi-)]TJ
0 -1.1795 TD
[(noids)-308.5(have)-304.9(no)-304(role)-306.5(in)-306.1(the)-303(management)-306.5(of)-305.7(acute)-304.2(pain.)41.9()]TJ
0 -1.1847 TD
[(However,)-577.9(it)-576.1(seems)-576.7(that)-574.9(the)-577.1(conclusions)-573.7(may)-579.6(have)]TJ
0 -1.1795 TD
[(been)-227.3(overstated)-230.3(given)-226(the)-225.4(limited)-227(number)-230.3(of)-228.1(studies)-228.6(in-)]TJ
T*
[(cluded)-368.8(in)-368.1(their)-372.2(review)-362.9(and)-369.5(lack)-368.6(of)-367.8(meta-analysis)-367.2(per-)]TJ
0 -1.1847 TD
[(formed.)-567.5(A)-564.9(meta-analysis)-563.8(offers)-567.5(a)-566.6(consolidated)-561.1(and)]TJ
0 -1.1795 TD
[(quantitative)-397.2(review,)-393.2(allowing)-387.9(for)-397(a)-395.9(more)-391.1(precise)-394.5(esti-)]TJ
0 -1.1847 TD
[(mate)-459.2(of)-450.6(the)-458.2(effect)-454.6(of)-455.7(the)-453(treatment.)-458(With)-453.2(that)-455.9(said,)]TJ
0 -1.1795 TD
[(our)-369.7(goal)-362.2(was)-363.7(to)-367.1(reassess)-366.7(this)-364(subject)-361.8(using)-366(systematic)]TJ
0 -1.1847 TD
[(review)-300.8(and)-302.3(meta-analysis)-294.8(methodology.)]TJ
1.0036 -1.1795 TD
[(The)-265.1(aim)-260.2(of)-264.3(this)-265.7(systematic)-266.2(review)-259.4(and)-266.1(meta-analysis)]TJ
-1.0036 -1.1847 TD
[(was)-244.7(to)-237.8(synthesize)-246.5(the)-240.9(best)-239(evidence)-245.5(surrounding)-241.9(the)-240.9(ef-)]TJ
0 -1.1795 TD
[(cacy)-344.1(of)-341.9(cannabinoids)-342.5(for)-345.2(acute)-345.6(pain)-342.3(using)-345.3(subjective)]TJ
T*
[(pain)-300.9(scores,)-301.6(and)-302.3(observed)-295.4(adverse)-299.7(effects.)]TJ
/F3 1 Tf
10.4607 0 0 10.4607 59.7543 464.7684 Tm
(Methods)Tj
/F7 1 Tf
10.959 0 0 10.959 59.7543 451.7857 Tm
.009 Tc
[(We)-299.2(conduct)-4.6(e).8(d)-293.5(a)-298.9(sys)-4.6(t).6(ematic)-294.1(r)-4.6(e).8(vi)-5.2(ew)-296.9(and)-298.7(m)-1.5(eta-anal)-4.8(ysis)]TJ
T*
.0097 Tc
[(on)-406.3(t)-3.9(h)2.7(e)-407.2(e)-3.7(fc)-3.7(a)1.8(c)-3.7(y)-406.6(and)-406.6(a)-3.4(dvers)-3.9(e)-407.2(events)-407.4(\(AEs\))-407.8(a)-3.4(ssociated)]TJ
0 -1.1847 TD
.0106 Tc
[(with)-431(usin)3.2(g)-426.4(c)-2.8(ann)3.2(a)2.7(bino)3.6(ids)-427.2(f)1.6(o)3.6(r)-427.2(th)3.6(e)-427(t)-3(reatment)-422(of)-427.8(acute)]TJ
0 -1.1795 TD
.0096 Tc
[(pain.)-439.7(T)2.8(his)-438.6(r)1.1(eview)-436(a)-3.5(dhere)-3.8(d)-437.8(to)-437.1(the)-438.3(r)-4(ecomm)9.6(e)-9.1(n)2.2(dations)]TJ
0 -1.1847 TD
.0105 Tc
[(outlined)-250.6(in)-255.5(the)-256.4(P)3.5(referred)-250.6(R)3.7(ep)]TJ
11.8828 0 TD
[(orting)-250.6(Items)-251.5(f)1.5(or)-251.5(System-)]TJ
-11.8828 -1.1795 TD
.0087 Tc
[(a)-4.4(t).3(ic)-221.9(Rev)-4.1(i)-.3(ews)-217(a)-4.4(nd)-221.4(M)8.7(e)-9.5(ta-)-4.6(a).8(n)-3.8(a).8(ly)-4.1(ses)-222.2(a).8(nd)-221.4(Cochran)-3.8(e)-216.8(Coll)-5.1(ab-)]TJ
0 -1.1847 TD
.0108 Tc
[(oratio)3.8(n)-296.6(g)3.2(u)3.1(i)-3.4(d)3.1(e)-2.6(lin)3.4(e)-2.6(s)-292.5(f)1.8(o)3.8(r)-292.5(th)3.8(e)-292.3(p)-2(erfo)3.8(rman)3.4(ce)-292.3(an)3.4(d)-291.7(r)-2.8(epo)3.8(r)2.3(tin)3.4(g)]TJ
0 -1.1795 TD
.0098 Tc
[(of)-268.2(s)-3.8(y)2.2(st)-3.8(emati)-4.4(c)-267.4(reviews)-272.8(a)1.9(nd)-266.9(meta-analys)-3.8(i).8(s.)]TJ
8.2191 0 0 7.3052 240.1511 366.0094 Tm
.0171 Tc
(8,9)Tj
/F8 1 Tf
10.4607 0 0 10.4607 59.7543 335.2251 Tm
0 Tc
[(Literature)-303.5(search)]TJ
/F7 1 Tf
10.959 0 0 10.959 59.7543 322.2991 Tm
.0085 Tc
[(A)-452.9(s)0(y)-4.3(s)0(te)-4.9(matic)-454.9(l)-.2(it)-5.1(era)-4.6(t).1(ur)-5.1(e)-449.8(s)0(e)-4.9(a).6(r)-5.1(c).3(h)-448.6(o)-3.6(f)-450.6(P)-3.7(ubMed,)-456.4(Emba)-4.6(se)-4.9(,)]TJ
0 -1.1847 TD
.012 Tc
[(Co)5(ch)5(ra)4.1(ne)-254.9(Da)4.1(t)3.6(a)-1.1(b)5(a)-1.1(s)3.5(e)3.8(s,)-256.3(an)4.6(d)-259.5(G)6.1(oo)5(gle)-260(S)4.1(c)3.8(h)-.2(o)5(l)-1.8(a)4.1(r)-260.3(fr)3.5(om)-257.2(in)4.6(ce)3.8(p-)]TJ
0 -1.1795 TD
.0104 Tc
[(tio)3.4(n)-297(to)-296.6(Jan)3(u)-2.4(ary)-297.2(2)-2.1(1)3.1(,)-294.1(20)3.1(19)3.1(,)-299.3(w)4.5(as)-292.9(perfo)3.4(r)1.9(med.)-294.1(We)-297.8(utilized)]TJ
0 -1.1847 TD
.0087 Tc
[(a)-501(s).2(truct)-4.9(u)1(re)-4.7(d)-495.6(s).2(e)-4.7(a).8(rc)-4.7(h)-494.9(s).2(t)-4.9(r).2(at)-4.9(egy)-500.7(w)2.8(i)-5.5(t).3(h)-494.9(k)-4.1(eywor)-4.9(d)1(s)-496.4(r)-4.9(elated)]TJ
0 -1.1795 TD
.01 Tc
[(to)-416()46.9().4(cannabinoids,)41.8()-413.5()41.8(cannabis)46.9()-418.6(o)-2.1(r)-412.3()41.8(marijuana)46.9()-418.6(AND)]TJ
0 -1.1847 TD
.0085 Tc
[()40.3()-1.1(ac)-4.9(ute)-325.6(p).8(a)-4.6(i)-.5(n)40.3()-321.9(o)1.5(r)-320.7()40.3(postope)-4.9(rat)-5.1(i)-.5(ve)-325.6(pai)-5.7(n)1.1(,)40.3()-321.9(u).8(ti)-5.7(lizi)-5.7(ng)-319.8(Me)-4.9(SH)]TJ
0 -1.1795 TD
.0094 Tc
[(t)-4.2(e)1.2(rms)-231.9(w)-1.6(her)-4.2(e)-231.6(possible.)-233(A)-229.6(m)-1.1(anual)-232.1(s).9(earch)-230.4(o)-2.7(f)-227.3(r)-4.2(elated)-231.1(c)-4(i).4(ta-)]TJ
T*
.0123 Tc
[(tio)5.3(n)-.2(s)-265.2(w)1.3(a)4.4(s)-270.3(a)4.4(l)3.6(so)-263.7(pe)4.1(rfo)5.3(r)-1.3(m)12.3(e)-6.4(d)4.6(.)]TJ
/F8 1 Tf
10.4607 0 0 10.4607 59.7543 205.7385 Tm
0 Tc
[(Study)-300.7(eligibility)]TJ
/F7 1 Tf
10.959 0 0 10.959 59.7543 192.7559 Tm
[(Peer-reviewed)-729.2(randomized-c)5.1(ontrolled)-723.2(clinical)-729.2(trials)]TJ
T*
[(comparing)-689.3(cannabinoids)-689.1(with)-687.3(placebo)-685.7(in)-688.9(patients)]TJ
0 -1.1847 TD
[(with)-273.4(acute)-268(pain)-269.9(were)-273.9(eligible)-268.1(for)-272.8(inclusion.)-268.6(We)-271.4(dened)]TJ
0 -1.1795 TD
[(acute)-283.5(pain)-285.4(as)-280.2(a)-282.1(distressing)-282.5(experience)-283.2(secondary)-283(to)-284.4(ac-)]TJ
0 -1.1847 TD
[(tual)-286.1(or)-279.3(potential)-284.7(tissue)-283(damage)-282.6(lasting)]TJ
/F6 1 Tf
15.5454 0 TD
(<)Tj
/F7 1 Tf
.5794 0 TD
[(3)-281.5(months.)-280.8(We)]TJ
-16.1248 -1.1795 TD
[(excluded)-214.2(any)-209.1(studies)-213.1(where)-208.5(the)-209.8(duration)-213.5(of)-207.4(pain)-213(was)]TJ
/F6 1 Tf
20.7599 0 TD
(>)Tj
/F7 1 Tf
.5794 0 TD
(3)Tj
-21.3393 -1.1847 TD
[(months,)-291.2(or)-289.6(the)-287.4(condition)-288.2(being)-292.6(studied)-289.9(was)-291.2(associated)]TJ
0 -1.1795 TD
[(with)-392.4(chronic)-386.3(pain)-394.1(\(i.e.,)-391.1(diabetic)-391.3(neuropathy,)-386.9(multiple)]TJ
T*
[(sclerosis\).)-310.6(Although)-307.9(there)-309.3(are)-309.1(a)-313.1(number)-307.9(of)-310.9(human)-304.3(ex-)]TJ
0 -1.1847 TD
[(perimental)-410.3(acute)-407.7(pain)-404.4(studies,)-408.9(we)-407.2(excluded)-410.8(them)-406.6(for)]TJ
0 -1.1795 TD
[(several)-367.9(reasons.)]TJ
8.2191 0 0 7.3052 128.5795 68.1449 Tm
(1024)Tj
10.959 0 0 10.959 152.5606 63.2692 Tm
[(First,)-367.2(there)-366.2(are)-371.2(signicant)-364.8(differ-)]TJ
14.4435 57.9085 TD
[(ences)-299.1(in)-295.7(trial)-295.9(design)-296.6(and)-302.3(patient)-294.9(population)-295.6(compared)]TJ
0 -1.1847 TD
[(with)-485.5(clinical)-491.2(trials.)-489.9(As)-485.4(well,)-491.1(cannabinoid)-489.2(impact)-486.3(on)]TJ
0 -1.1795 TD
[(experimental)-374.7(acute)-371.5(pain)-378.5(was)-374(recently)-370.3(explored)-379.4(as)-373.3(the)]TJ
0 -1.1847 TD
[(primary)-463.2(topic)-459.3(of)-460.9(a)-463.1(well-done)-462.9(systematic)-462.8(review)-461.2(and)]TJ
0 -1.1795 TD
[(meta-analysis)5.3(.)]TJ
8.2191 0 0 7.3052 372.7558 650.9479 Tm
(25)Tj
10.959 0 0 10.959 385.8519 646.0723 Tm
[(Pain)-476.2(outcomes)-474.1(of)-476.4(interest)-475.2(consisted)]TJ
-6.8441 -1.1847 TD
[(of)-259.2(validated)-259.2(subjective)-262.5(pain)-259.6(scores,)-260.2(including)-258.8(the)-261.6(visual)]TJ
0 -1.1795 TD
[(analog)-284.4(scale)-284.6(\(VAS\),)-285.9(McGill)-283.2(Pain)-284.8(Questionnaire,)-288.5(or)-284.5(the)]TJ
T*
[(numeric)-297.4(rating)-302.2(scale)-300.1(\(NRS\).)]TJ
.9984 -1.1847 TD
[(Exclusion)-392.1(criteria)-388.4(included)-390.4(the)-390.9(following:)-385(\(1\))-392.1(trials)]TJ
-.9984 -1.1795 TD
[(focusing)-592(on)-593.7(chronic)-593.3(pain)-590.6(or)-594.8(conditions)-591.6(associated)]TJ
0 -1.1847 TD
[(with)-314.8(chronic)-313.9(pain;)-315.7(\(2\))-314.5(nonhuman)-315.7(trials)-314.7(or)-315.5(nonclinical)]TJ
0 -1.1795 TD
[(trials;)-417.5(\(3\))-412.8(abstracts)-414.6(or)-419(posters)-413.6(from)-417.8(conferences;)-413.9(and)]TJ
0 -1.1847 TD
[(\(4\))-547.3(trials)-547.5(with)-542.4(incomplete)-548.8(or)-543.1(absent)-549.1(pain)-549.2(outcome)]TJ
0 -1.1795 TD
[(data.)-305.3(Titles)-303(and)-307.4(abstracts)-306(were)-304.9(then)-305.1(screened)-307.9(for)-303.8(eligi-)]TJ
0 -1.1847 TD
[(bility)-230.7(by)-231.8(two)-233.3(independent)-232(reviewers)-238(\(N.N.,)-230.6(K.G.\))-237(utiliz-)]TJ
0 -1.1795 TD
[(ing)-396.4(the)-396.1(Rayyan)-396.9(QCRI)-394.6(software.)]TJ
8.2191 0 0 7.3052 452.7495 508.4786 Tm
(26)Tj
10.959 0 0 10.959 464.9951 503.603 Tm
[(Any)-393.6(disagreements)]TJ
-14.0659 -1.1795 TD
[(on)-324.7(eligibility)-330.1(led)-324.6(to)-330.9(inclusion)-326.2(of)-331.6(the)-323.7(study)-329.5(for)-329.7(full-text)]TJ
0 -1.1847 TD
[(review)-295.7(by)-299.1(the)-303(primary)-297.6(author)-299.9(\(A.G.\).)]TJ
/F8 1 Tf
10.4607 0 0 10.4607 310.8472 451.7857 Tm
[(Data)-296.9(extraction)]TJ
/F7 1 Tf
10.959 0 0 10.959 310.8472 438.8597 Tm
.0147 Tc
[(Two)-344(i)-4.7(nvestigators)-345.5(\()-4.4(N)3.6(.N.,)-346.7(K.G.\))-345.9(c)1.3(ollected)-349.9(all)-345.7(r)-4.1(elevant)]TJ
T*
.0145 Tc
[(inf)-4.9(o)2.4(rmat)-4.2(ion)-303.2(r).9(egarding)-303.5(study)]TJ
12.069 0 TD
.0162 Tc
[(and)-301.9(p)3.4(atient)-297.4(po)4.1(pu)3.4(lation)3.7(,)]TJ
-12.069 -1.1795 TD
.0137 Tc
[(inc)-4.8(l)-.1(ud)-4.3(ing)-340.5(t)-5(he)-341.1(st)-5(udy)-340.5(d)-4.3(e).3(si)-5.7(gn,)-337.3(p)-4.3(atie)-4.8(nt)-341.3(d)-4.3(e).3(mogr)-5.1(aphic)-341.1(i)-.5(n-)]TJ
0 -1.1847 TD
.0149 Tc
[(for)-3.9(m)4.4(ation,)-356.8(and)-354.9(s)1.3(ample)-355.4(s)-3.9(ize.)-356.8(I)-3.9(n)2.4(tervention)-354.6(details)-355.7(a)1.8(b-)]TJ
0 -1.1795 TD
.0144 Tc
[(str)-4.4(acted)-598.5(i).2(ncluded)-598.5(t)-4.3(he)-599.1(type,)-600.5(d)-3.6(osage,)-600.5(and)-598.5(r).8(oute)-599.1(of)]TJ
0 -1.1847 TD
.014 Tc
[(cannabinoid)-516.2(u)1.2(ti)-5.4(lize)-4.5(d.)-512.9(Outc)-4.5(omes)-517(coll)-5(ecte)-4.5(d)-511(include)-4.5(d)]TJ
0 -1.1795 TD
.0147 Tc
[(the)-521.2(t)-4(ype)-521.2(of)-516.8(pain)-520.3(s)-4.1(c)1.3(ale)-521.2(u)-3.3(sed,)-522.6(as)-521.4(well)-516.5(as)-521.4(the)-521.2(m)-1(ean)]TJ
T*
.0149 Tc
[(score)-417.5(a)-3.3(nd)-422.1(standard)-417(d)-3.1(evi)-4.5(a)1.8(tion)-416.7(\(SD\))-418.1(at)-417.7(baseline,)-418.9(a)1.8(nd)]TJ
0 -1.1847 TD
.0146 Tc
[(change)-536.8(from)-533.9(basel)-4.4(i).4(ne)-536.8(or)-537(pos)-4.2(t)1(operative)-536.8(p)-3.4(ain)-541.1(s)1(core)]TJ
0 -1.1795 TD
.0154 Tc
[(and)-628.6(S)2.3(D)-631.7(w)-.8(hen)-628.3(a)2.3(vailable.)-630.5(T)3.4(he)-629.1(following)-628.5(decisions)]TJ
0 -1.1847 TD
.0142 Tc
[(were)-490.6(made)-490.6(regarding)-490(t).6(he)-485.4(calculat)-4.5(ion)-489.8(o)7.2(f)-486.3(e)6(ffe)6(c)6(t)-485.6(s)5.7(i)5.2(ze)]TJ
0 -1.1795 TD
.0096 Tc
[(for)-552.4(t)-4(he)-552.1(data.)-553.5(W)-.1(hen)-551.3(s)1.1(tudies)-552.4(utilized)-551.6(multiple)-552.1(pai)-4.6(n)]TJ
0 -1.1847 TD
.0102 Tc
[(scores)-277.6(\(i.e.,)-283.9(on)-281.7(movement)-277.5(vs)]TJ
11.5776 0 TD
.2941 Tc
[(.r)285.6(e)285.9(s)280.5(t)285.7(\))285.3(,a)6.9(m)283.6(e)285.9(a)281(n)2.2(p)286.4(o)282(o)287.1(l)285.4(e)280.7(d)7.1(e)280.7(f)285.1(-)]TJ
-11.5776 -1.1795 TD
.0101 Tc
[(fect)-324.2(size)-324(was)-324.3(c)-3.3(omputed)-323.5(f)1.1(or)-324.3(the)-324(o)3.1(verall)-324.5(met)-3.5(a)2.2(-analysi)-4.1(s.)]TJ
0 -1.1847 TD
.0094 Tc
[(Whe)-4(n)-349.7(multiple)-355.8(cannabinoi)-4.8(d)-350(t)-4.2(ypes)-356(or)-356(doses)-356(w)-1.6(ere)-355.7(e)1.2(x-)]TJ
0 -1.1795 TD
[(amined)-355.2(within)-354.9(a)-350.3(s)-4.2(ingle)-355.8(s).9(tudy,)-357.2(t)1(hese)-355.8(were)-350.6(handled)-350(a)-3.7(s)]TJ
T*
.0079 Tc
[(ind)-4.9(i)-1.1(v)-4.9(i)-1.1(du)-4.9(al)-218(c)-5.5(o).9(mpa)-5.2(r)-.6(is)-5.7(on)-4.6(s)-217.8(a)0(n)-4.6(d)-217(th)-4.3(e)-217.6(p)-4.9(lac)-5.5(e)-.3(bo)-221.5(gr)-5.7(ou)-4.9(p)-217(w)-3.1(as)-217.8(d)-4.9(i)-1.1(-)]TJ
0 -1.1847 TD
.0122 Tc
[(v)4.6(i)3.2(de)4(d)-202.4(b)5.2(y)-202.3(t)3.8(he)-197.8(nu)4.5(mb)5.2(er)-198(of)-198.6(co)5.2(mp)]TJ
11.8 0 TD
.0087 Tc
[(a)-4.4(r).2(at)-4.9(ors)-4.9(.)-202.7(When)-205.6(pai)-5.5(n)-200.4(me)-4.7(a-)]TJ
-11.8 -1.1795 TD
.0098 Tc
[(surements)-826.4(w)-1.2(ere)-826.1(t)1.4(aken)-825.3(at)-821.1(multiple)-826.1(time)-826.1(points)]TJ
0 -1.1847 TD
[(following)-313.4(t)-3.8(he)-319.1(pain)-318.3(stimulus,)-315.4(t)1.4(he)-319.1(raw)-316.8(p)-3(ain)-318.3(s)1.3(core)-314(from)]TJ
0 -1.1795 TD
[(the)-293.3(l)-4(argest)-298.6(s)-3.8(i).8(ngle)-298.4(time)-298.4(point)-293.5(c)-3.6(ontrast)-298.6(b)2.8(etween)-297.6(t)-3.8(h)2.8(e)-298.5(a)1.9(c-)]TJ
0 -1.1847 TD
.0095 Tc
[(tive)-376.3(and)-375.8(p)-3.3(lac)-3.9(e)1.3(bo)-375.1(conditions)-381.8(was)-376.6(t)1.1(aken)-380.7(\(peak)-380.9(e)1.3(ff)-4.7(ect)-4.1(\).)]TJ
0 -1.1795 TD
.0117 Tc
[(I)3.3(f)-225(r)3.2(a)3.8(w)-221.8(p)-1.1(a)3.8(i)2.7(n)-223.3(s)-1.9(c)3.5(o)4.7(re)3.5(s)-224.4(a)3.8(t)-224.3(s)3.2(pe)3.5(c)3.5(i)-2.5()4.7(c)-224.1(t)3.3(i)2.7(me)-224.1(p)4(o)-.4(in)4.3(ts)-219.2(we)3.5(re)-218.9(un)4.3(av)4.1(ail-)]TJ
0 -1.1847 TD
.0087 Tc
[(able,)-218.2(w)-2.3(e)-216.8(u)1(til)-5.1(i)-.3(ze)-4.7(d)-216.2(t).3(he)-216.8(a)-4.4(v)1.1(e)-4.7(r).2(age)-216.8(p)1(ai)-5.5(n)-215.9(s).2(core)-4.7(s)-211.9(o)-3.4(ve)-4.7(r)-217(t).3(he)-216.8(s)-4.9(t).3(udy)]TJ
0 -1.1795 TD
.0099 Tc
[(durat)-3.7(i).9(on,)-423.9(i)-4.3(f)-423.3(p)-2.9(rovided.)-423.9(Pain)-426.8(scor)-3.7(es)-427.9(were)-427.7(recor)-3.7(d)2.2(ed)-422(as)]TJ
0 -1.1847 TD
.0093 Tc
[(mean)-474(and)-469.1(S)-3.8(D)-467(w)-1.7(he)-4.1(n)-468.8(a)-3.8(vai)-4.9(l).6(able.)-471.1(W)-.4(hen)-474(n)1.9(ot)-469.9(re)-4.1(ported,)]TJ
0 -1.1795 TD
.0085 Tc
[(SD)-442(wa)-4.6(s)-439.7(c).3(al)-5.3(cul)-5.3(a).6(te)-4.9(d)-438.9(f)-.5(rom)-436.6(t).1(he)-439.4(ot)-5.1(he)-4.9(r)-439.7(a).6(va)-4.6(ila)-4.6(b)1.5(le)-439.4(data)-439.1(i)-5.7(n)]TJ
T*
.0096 Tc
[(the)-195.2(a)-3.5(rti)-4.6(c)1.4(le.)-201.8(F)-3.2(or)-200.6(data)-200(presented)-199.8(e)1.4(xclusively)-199.7(in)-199.5(graph)-199.2(f).6(or-)]TJ
0 -1.1847 TD
.0098 Tc
[(mat,)-356.8(we)-355.3(utilized)-354.8(a)-355(v)2.2(alidated)-349.6(data)-355(extraction)-354.5(software)]TJ
0 -1.1795 TD
.0084 Tc
[(\(Web)-3.7(Pl)-5.4(otDig)-4.4(i)-.6(tiz)-5(e).2(r,)-611.7(v)-4.4(e).2(rs)-5.2(ion)-614.6(4)1.1(.1)-4.1(;)-611.7(A)2.2(n)-4.1(k).8(it)-615.6(Ro)-3.7(hat)-5.2(g).8(i\))-610.8(t)-5.2(o)]TJ
/F3 1 Tf
9.9626 0 0 9.9626 59.7543 753.8455 Tm
0 Tc
[(CA)-8.2(NNABI)-9.1(NOIDS)-304.1(IN)-301(AC)-8.2(UTE)-299.6(PAI)-10(N)]TJ
47.5445 0 TD
(291)Tj
ET
endstream
endobj
39 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
10.959 0 0 10.959 62.022 697.8896 Tm
0 0 0 rg
.009 Tc
0 Tw
[(record)-521.2(out)-4.6(c).8(omes.)-523.1(A)-2.4(Es)-527.1(we)]TJ
11.1016 0 TD
.0094 Tc
[(re)-521.3(r)-4.2(ecorded)-525.9(by)-525.9(type)-521.3(and)]TJ
-11.1016 -1.1847 TD
.0113 Tc
[(ov)3.7(e)3.1(r)-2.3(a)3.4(l)2.6(l)-271.5(i)2.3(n)3.9(c)-2.1(id)3.6(en)3.9(ce)-265.9(fo)4.3(r)-271.3(e)3.1(ac)3.1(h)-269.9(s)2.8(tud)3.6(y)-270.5(a)3.4(n)-1.2(d)-270.5(c)3.1(lassie)3.1(d)-270.5(a)3.4(s)-271.3(s)2.8(eri-)]TJ
0 -1.1795 TD
.2982 Tc
[(o)286.1(u)290.5(so)286.1(rn)285.7(o)291.2(n)285.7(s)289.7(e)290(r)284.6(i)289.2(o)291.2(u)285.4(si)289.2(f)-5.7(r)289.7(e)290(p)285.4(o)291.2(r)284.6(t)289.8(e)290(d)285.4(.)]TJ
/F8 1 Tf
10.4607 0 0 10.4607 62.022 647.5463 Tm
0 Tc
[(Study)-300.7(appraisal)]TJ
/F7 1 Tf
10.959 0 0 10.959 62.022 634.6203 Tm
-.0143 Tc
[(Three)-255.3(i)2.6(nde)3.4(p)-1.3(e)3.4(n)-1(de)3.4(nt)-255.5(review)5.7(ers)-260.7(\()2.8(A.G.,)-256.7(N).5(.N.,)-256.7(K.G.\))-255.9(a)-1.5(ssesse)3.4(d)]TJ
0 -1.1847 TD
[(th)4.5(e)-188.1(m).9(ethodological)-188.6(qu)]TJ
8.5202 0 TD
.1731 Tc
[(a)185.9(l)190.3(i)184.8(t)190.6(ya)185.9(n)186.4(d)-.1(s)190.5(t)185.4(u)191.3(d)186.1(yv)186.2(a)185.9(l)190.3(i)190(d)186.1(i)190(t)185.4(yu)186.1(t)190.6(i)190(l)185.1(i)190(z)185.6(i)190(n)186.4(g)0(t)185.4(h)192(e)]TJ
-8.5202 -1.1795 TD
-.0155 Tc
[(Cochrane)-313.4(ri)-3.8(sk)-312.8(of)-309.1(bias)-313.7(tool)-308.7(through)-312.2(R)-1.6(eview)-311.1(M).4(anager)-308.5(5.3)]TJ
0 -1.1847 TD
-.0148 Tc
[(\()-2.9(T)4.3(he)-224.8(Nordic)-224.8(Cochrane)-224.8(Center)]TJ
11.5724 0 TD
-.0151 Tc
[(,)-226.5(T)-1.2(he)-225.1(Cochrane)-225.1(Collabora-)]TJ
-11.5724 -1.1795 TD
-.0177 Tc
[(t)-5.4(i)-.8(on,)-291.2(2)-4.3(01)-4.3(4,)-291.1(Cope)-5.2(n)-4.4(h)1.2(a)-4.9(g).6(e)-5.2(n)-4.4(,)-286(D)-2.6(e)-5.2(n)-4.4(ma)-4.9(r)-5.5(k).5(\))-290.3(s)-5.5(of)-6(twar)-5.5(e.)]TJ
8.2191 0 0 7.3052 253.4172 587.6786 Tm
-.0237 Tc
(27)Tj
10.959 0 0 10.959 264.4156 582.803 Tm
-.0149 Tc
[(Bias)-318.2(was)]TJ
-18.4682 -1.1795 TD
[(assessed)-364(utilizing)-363.9(t)2.6(he)-364.5(follow)]TJ
10.9309 0 TD
-.0159 Tc
[(ing)-364.9(d)-2.9(omains:)-366.9(s)-3.7(el)-3.9(ec)-3.4(tion)-364.7(bias,)]TJ
-10.9309 -1.1847 TD
-.0131 Tc
[(pe)4.6(rfor)4.3(manc)4.6(e)-254.1(b)5.8(ia)4.9(s,)-250.3(de)4.6(te)4.6(ct)4.4(ion)-253.2(b)5.8(ia)4.9(s,)-250.3(at)4.4(tr)4.3(ition)-248.1(b).6(ia)4.9(s,)-250.3(r)4.3(e)-.6(po)5.8(rt)4.4(ing)]TJ
0 -1.1795 TD
-.0178 Tc
[(b)-4.1(i)-.9(a)-5(s)-.4(,)-306.8(a)-5(nd)-310(ot)-5.5(he)-5.3(r)-305.6(b)-4.1(ias)-5.6(e)-5.3(s.)-306.8(Ris)-5.6(k)-304.8(of)-306.2(b)-4.1(i)-.9(a)-5(s)-305.6(fo)-4.1(r)-305.6(e)-5.3(ac)-5.3(h)-304.2(o)-4.1(f)-306.2(t)-.3(h)-4.1(e)-.1(s)-5.6(e)-305.4(d)-4.8(o)1.1(-)]TJ
0 -1.1847 TD
-.0137 Tc
[(mains)-337.7(w)1.1(as)-337.7(de)4(te)4(rmine)4(d)-342.1(t)3.8(o)-341.4(be)-337.5(low)-340.3(r)3.7(is)3.7(k,)-338.9(high)-336.3(risk)4.5(,)-344.1(o)5.2(r)-342.9(u)-.7(n)4.8(-)]TJ
0 -1.1795 TD
-.0141 Tc
[(clea)3.9(r)-307.1(r)3.3(isk.)-303.1(The)-301.7(i)-2.4(n)4.4(c)-1.6(lud)4.1(e)-1.6(d)-306.3(s)3.3(tu)4.1(dies)-301.9(were)-306.8(then)-300.8(give)3.6(n)-306(a)-306.5(g)4.2(r)-1.9(a)3.9(d)-1.1(e)]TJ
0 -1.1847 TD
-.0148 Tc
[(of)-298(high)-296(risk,)-303.8(m).5(o)4.1(d)-1.8(erate)-302.4(r)2.6(isk,)-303.8(o)4.1(r)-302.6(low)-300(r)2.6(isk.)]TJ
.9984 -1.1795 TD
0 Tc
[(The)-218.6(quality)-216.9(of)-212.6(the)-215(evidence)-219.6(and)-214.3(the)-215(condence)-219.2(in)-212.9(the)]TJ
-.9984 -1.1847 TD
[(estimate)-188.1(of)-186.7(the)-189.2(effect)-190.8(across)-188.2(outcomes)-189.6(were)-185.9(assessed)-190(uti-)]TJ
0 -1.1795 TD
-.0001 Tc
[(lizing)-401.7(the)-401.4(Grading)-400.6(of)-404.1(Recommendations)-401.7(Assessment,)]TJ
T*
0 Tc
[(Development)-289.2(and)-291.9(Evaluation)-290.6(\(GRADE\))-292.3(approach.)]TJ
8.2191 0 0 7.3052 283.5779 458.1353 Tm
(28,29)Tj
10.959 0 0 10.959 62.022 440.3337 Tm
-.0001 Tc
[(Accordingly,)-473.3(data)-471.7(from)-474.9(randomized-controlled)-472.9(trials)]TJ
T*
0 Tc
[(are)-407.4(considered)-411.3(high-quality)-405.7(evidence,)-405.2(but)-405.9(the)-411.6(quality)]TJ
0 -1.1847 TD
[(can)-287.3(be)-279(rated)-288.9(down)-281.4(due)-282.2(to)-284.4(risk)-287.1(of)-279.9(bias,)-285.1(imprecision,)-283.6(in-)]TJ
0 -1.1795 TD
[(directness,)-299(imprecision,)-304.3(and)-297.1(publication)-299.9(bias.)]TJ
8.2191 0 0 7.3052 260.3338 406.3747 Tm
(29)Tj
/F8 1 Tf
10.4607 0 0 10.4607 62.022 374.0597 Tm
[(Data)-302.3(analysis)]TJ
/F7 1 Tf
10.959 0 0 10.959 62.022 361.1338 Tm
[(Pain)-274.5(scores)-276.4(were)-279.1(reported)-276.2(as)-275(the)-277.1(mean)-277.1(pain)-275.1(scores)-276.4(fol-)]TJ
T*
[(lowing)-200.7(the)-204.7(pain)-202.7(stimulus)-203.4(along)-198.9(with)-206.2(95%)-200.9(condence)-198.5(in-)]TJ
0 -1.1847 TD
[(tervals)-331.9(\(CIs\).)-334.8(Our)-332.5(index)-335.1(instrument)-332.2(of)-331.6(choice)-332.1(was)-332.6(the)]TJ
0 -1.1795 TD
[(VAS,)-345.9(which)-347.5(utilizes)-347(a)-349.3(scale)-346.7(from)-345.4(0)-348.7(t)0(o)-346.4(10,)-350.1(with)-345.8(higher)]TJ
0 -1.1847 TD
[(scores)-312.6(representing)-314.7(increased)-311.5(pain.)-310.6(All)-313.2(subjective)-314.2(pain)]TJ
0 -1.1795 TD
[(scores)-431.6(were)-429.1(transformed)-432.9(to)-429.2(match)-430(our)-431.8(index)-433.3(instru-)]TJ
0 -1.1847 TD
[(ment)-360.4(leading)-361.6(to)-362(mean)-359.9(pain)-363(scores)-364.4(between)-358.4(0)-364.2(and)-359.2(10.)]TJ
0 -1.1795 TD
[(The)-213.4(mean)-215.1(pain)-213(scores)-214.3(were)-211.8(analyzed)-213.5(through)-213.5(a)-209.6(random)]TJ
0 -1.1847 TD
[(effects)-411.4(model)-404.2(based)-406.5(on)-407.5(the)-406.4(inverse)-409.1(variance)-406.1(method.)]TJ
0 -1.1795 TD
[(Total)-452.6(and)-447.1(serious)-455.6(AEs)-451.1(were)-449.8(pooled)-449.7(and)-452.3(odds)-449.8(ratios)]TJ
T*
[(\(ORs\))-302.6(were)-299.8(calculated)-298.7(between)-296.4(the)-297.8(two)-300.6(groups.)]TJ
.9984 -1.1847 TD
.0102 Tc
[(Heterogeneity)-271.6(w)4.3(as)-272.4(quan)]TJ
9.8342 0 TD
.0089 Tc
[(t)-4.7(i)-.1(ed)-272.9(u)1.2(ti)-5.3(lizi)-5.3(ng)-272.9(the)]TJ
/F9 1 Tf
7.527 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 267.0236 223.5401 Tm
(2)Tj
10.959 0 0 10.959 274.3369 218.6645 Tm
.0113 Tc
[(st)2.9(a)3.4(t)-2.3(is)2.8(-)]TJ
-19.3735 -1.1795 TD
.0095 Tc
[(ti)-4.7(c,)-269.1(which)-266.5(e)1.3(st)-4.1(imates)-268(the)-267.7(p)1.8(roporti)-4.7(o)2.5(n)-266.9(o)-2.6(f)-268.5(t)1.1(otal)-268.2(variabil)-4.3(ity)]TJ
0 -1.1847 TD
[(among)-479.2(s)1(t)-4.1(u)1.8(dies)-480.1(due)-479.8(t)1.1(o)-478.6(h)2.5(e)-3.9(t)1.1(er)-4.1(ogene)-3.9(i).5(ty)-479.2(as)-474.9(oppose)-3.9(d)-479.3(t)1.1(o)]TJ
0 -1.1795 TD
.0093 Tc
[(chance)-267.9(alone)-4.1(.)]TJ
8.2191 0 0 7.3052 122.3433 184.7054 Tm
.0102 Tc
[(30)-7.4(,3)-7.4(1)]TJ
10.959 0 0 10.959 143.3763 179.8298 Tm
.0068 Tc
[(Th)-5.4(e)]TJ
/F9 1 Tf
1.852 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 167.4708 184.7054 Tm
(2)Tj
10.959 0 0 10.959 174.3873 179.8298 Tm
.0093 Tc
[(values)-268.2(were)-267.9(then)-267.1(int)-4.3(e)1.1(rpret)-4.3(e)1.1(d)]TJ
-10.2532 -1.1847 TD
[(accordi)-4.8(n)2(g)-298.2(t)1(o)-297.6(t)-4.2(he)-298.8(Cochrane)-298.8(Handbook;)]TJ
/F9 1 Tf
16.0834 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 242.022 171.7228 Tm
(2)Tj
10.959 0 0 10.959 249.3354 166.8472 Tm
.0073 Tc
[(0)-5.2(40)-5.2(%)-298(r)-1.2(e)-6.1(p)-.4(-)]TJ
-17.0922 -1.1795 TD
.0099 Tc
[(resenting)-370.2(l)1.2(ow)-368.4(heterogeneit)-3.7(y,)]TJ
/F9 1 Tf
12.0587 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 197.9149 158.7968 Tm
(2)Tj
10.959 0 0 10.959 206.022 153.9212 Tm
.0115 Tc
[(30)4.2(6)4.2(0%)-366.3(represen)4.1(tin)4.1(g)]TJ
-13.1399 -1.1847 TD
.0095 Tc
[(moderate)-288.4(heterogeneit)-4.1(y,)]TJ
/F9 1 Tf
10.1601 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 177.1086 145.8141 Tm
(2)Tj
10.959 0 0 10.959 184.3086 140.9385 Tm
.0107 Tc
[(50)3.4(9)3.4(0)3.4(%)-289.5(representing)-286.6(sub)3.7(-)]TJ
-11.1585 -1.1795 TD
.0088 Tc
[(st)-4.8(antial)-418.9(he)-4.6(ter)-4.8(o)1.8(ge)-4.6(ne)-4.6(ity,)-414.7(and)]TJ
/F9 1 Tf
11.4844 0 TD
0 Tc
(I)Tj
/F7 1 Tf
8.2191 0 0 7.3052 191.622 132.8882 Tm
(2)Tj
10.959 0 0 10.959 200.2393 128.0126 Tm
.0078 Tc
[(75)-4.7(10)-4.7(0%)-416.5(re)-5.6(pr)-5.8(ese)-5.6(n).4(ti)-6.4(ng)]TJ
-12.6122 -1.1847 TD
.0084 Tc
[(cons)-5.2(ide)-5(r)-.1(able)-377.4(he)-5(ter)-5.2(o)1.4(g)-4.4(e).2(ne)-5(ity)-4.4(.)]TJ
8.2191 0 0 7.3052 184.9322 119.9055 Tm
.0107 Tc
(27)Tj
10.959 0 0 10.959 197.1212 115.0299 Tm
.0098 Tc
[(We)-376(planned)-375.5(t)1.4(o)-374.8(s)1.3(tratify)]TJ
-12.3277 -1.1795 TD
.5297 Tc
[(o)517.6(u)522(ra)521.8(n)522.3(a)516.6(l)521(y)522.1(s)516.1(i)520.7(sb)522.7(yt)521.3(y)522.1(p)516.9(e)4.2(o)517.6(fc)516.3(a)521.8(n)517.2(n)522.3(a)521.8(b)517.6(i)520.7(n)517.2(o)522.7(i)520.7(d)-.5(a)521.8(n)517.2(dr)521.2(o)522.7(u)516.9(t)521.3(e)-1(o)522.7(f)]TJ
T*
.0092 Tc
[(admini)-5(str)-4.4(a)1.3(tion)-463.7(to)-463.4(explore)-464.6(r).7(esults)-464.9(wi)-5(th)-463.4(moderate)-464.6(or)]TJ
0 -1.1847 TD
[(subs)-4.3(tantial)-439.1(h)-2.9(ete)-4.1(r).8(ogeneity)]TJ
10.336 0 TD
.0094 Tc
[(.)-439.9(F)-3.4(orest)-443.9(p)1.7(lots)-444(were)-443.7(visually)]TJ
-10.336 -1.1795 TD
[(inspect)-4.1(ed)-298.2(t)-4.1(o)-297.5(as)-4.1(ses)-4.1(s)-299(for)-299(p)-3.3(ublication)-297.9(bias.)]TJ
/F3 1 Tf
10.4607 0 0 10.4607 313.0582 698.2297 Tm
0 Tc
(Results)Tj
/F7 1 Tf
10.959 0 0 10.959 313.0582 685.2471 Tm
[(Ou)17.4(r)-158.5(s)0(e)19.5(a)0(r)19.8(c)0(h)-154.9(i)11.7(d)13(e)0(n)15.5(t)12.3(i)11.7()0(e)21(d)-162.9(12)21.7(57)-149.1(ci)19(ta)19.9(ti)18.8(on)21.9(s)-163.7(a)12.8(ft)18.8(e)12.5(r)-163.7(e)12.5(x)0(c)20.1(l)0(u)19.9(s)0(i)18.7(o)0(n)-148.8(o)0(f)-150.5(d)0(u)15.7(-)]TJ
T*
[(pl)19.9(ic)19(at)19.9(es)19.5(.)-159.6(Twen)-7.5(ty-ve)-171.1(articl)-9.3(es)-171.9(underwent)-177.8(full-text)-178.6(review,)]TJ
0 -1.1847 TD
[(and)-224.7(six)-222(articles)-227.7(were)-222.2(assessed)-226.2(to)-222.3(be)-222.1(eligible)-226.7(after)-223.1(review-)]TJ
0 -1.1795 TD
[(ing)-417.1(the)-411.6(inclusion)-419.3(and)-410.9(exclusion)-419.1(criteria)-414.3(\(Fig.)-446.2(1\).)]TJ
8.2191 0 0 7.3052 532.1762 651.288 Tm
[(32)-8.1(37)]TJ
10.959 0 0 10.959 313.0582 633.4297 Tm
[(Publi)-8.3(cation)-301.3(years)-304.5(range)-8.5(d)-297.4(f)0(r)-7.2(o)0(m)-296.9(1981)-303.3(to)-299.9(2017.)]TJ
/F8 1 Tf
10.4607 0 0 10.4607 313.0582 607.5778 Tm
[(Study)-306.1(characteristics)]TJ
/F7 1 Tf
10.959 0 0 10.959 313.0582 594.5951 Tm
[(Relevant)-326.9(study)-324.3(characteristics)-326.1(and)-323(treatment)-324.2(informa-)]TJ
T*
[(tion)-274.9(are)-272.9(provided)-275.4(in)-275(Table)-271.3(1.)-275.6(The)-275.5(study)-272.6(sample)-273.9(ranged)]TJ
0 -1.1847 TD
[(from)-319.6(30)-319.8(to)-320.6(340)-316.7(participants,)-320.2(for)-319.4(a)-318.3(total)-319.7(of)-321.2(678)-316.7(partici-)]TJ
0 -1.1795 TD
[(pants.)-271.9(Of)-268.5(the)-271.9(six)-268.6(studies)-270(included,)-270.7(two)-269.5(were)-268.7(conducted)]TJ
0 -1.1847 TD
[(in)-269.8(the)-271.9(United)-268.7(States,)-271(two)-264.4(in)-269.9(Canada,)-271.8(one)-270.9(in)-269.9(the)-266.8(United)]TJ
0 -1.1795 TD
[(Kingdom,)-241.2(and)-235(one)-239.8(multinational)-237.2(trial)-233.8(completed)-240.1(in)-238.8(the)]TJ
0 -1.1847 TD
[(United)-299.7(Kingdom,)-303.3(Italy,)-298.9(and)-297.1(Germany.)]TJ
1.0036 -1.1795 TD
[(The)-280.7(six)-289.2(included)-281.7(studies)-285.5(were)-284.2(randomized,)-283.1(placebo-)]TJ
-1.0036 -1.1847 TD
[(controlled,)-218.5(parallel-group)-216.1(trials)-216.4(\()]TJ
/F9 1 Tf
12.8864 0 TD
(n)Tj
/F6 1 Tf
.6984 0 TD
(=)Tj
/F7 1 Tf
.7191 0 TD
[(678\).)-216.1(Three)-214.6(studies)]TJ
-14.3038 -1.1795 TD
[(examined)-532.4(multiple)-524.1(cannabinoid)-525.5(doses,)-530.5(leading)-527.2(to)-522.3(a)]TJ
T*
[(total)-485.2(of)-481.6(11)-485.3(cannabinoid)-484.1(intervention)-479.2(versus)-488.6(placebo)]TJ
0 -1.1847 TD
(comparisons.)Tj
8.2191 0 0 7.3052 371.1117 457.0014 Tm
(3237)Tj
10.959 0 0 10.959 324.0566 439.1999 Tm
-.014 Tc
[(Table)-353.3(2)-357.5(summarizes)-353.6(the)-353.3(r)-1.8(oute)-353.3(of)-354.1(administration)-352.4(uti-)]TJ
-1.0036 -1.1847 TD
-.0134 Tc
[(lized)-202.1(f)-1.7(o)5.5(r)-202.9(the)-197.5(i)-1.7(ncluded)-202.1(s)-1.2(tu)4.8(dies)]TJ
10.8999 0 TD
-.0144 Tc
[(.)-205.1(O).4(ral)-204.1(c)-1.9(annabinoids)-203.9(w).4(ere)-203.7(e)-1.9(x-)]TJ
-10.8999 -1.1795 TD
-.0139 Tc
[(amined)-373.3(in)-373(5/6)-373(\()-2(8)4.7(3)-.5(%\))-379.6(o)5(f)-379.9(the)-373.9(i)-2.2(ncluded)-373.3(s)-1.7(tudies.)-375.3(T)0(hree)-379.1(of)]TJ
0 -1.1847 TD
[(these)-265.1(t)-1.5(rials)-260.2(e)-1.3(xamined)-264.6(synthetic)]TJ
/F10 1 Tf
12.1363 0 TD
0 Tc
(D)Tj
/F7 1 Tf
8.2191 0 0 7.3052 453.203 405.1841 Tm
(9)Tj
10.959 0 0 10.959 457.0015 400.3086 Tm
-.014 Tc
[(-tetrahydrocannab)4.9(i)-2.3(nol)]TJ
-13.1347 -1.1795 TD
0 Tc
[(\(THC\))-538(in)-528.5(the)-530.6(form)-531.7(of)-533.3(nabilone)-533.2(\(2\))-531.8(and)-535.1(AZD1940)]TJ
0 -1.1847 TD
(\(1\).)Tj
8.2191 0 0 7.3052 328.3086 379.2755 Tm
[(32,35,3)-10.8(6)]TJ
10.959 0 0 10.959 357.8456 374.3999 Tm
[(One)-202.6(study)-205.3(examined)-206.5(the)-204.7(effect)-9.7(s)-199.9(o)0(f)-202.3(a)-204.5(synthetic)]TJ
-4.0868 -1.1795 TD
.0172 Tc
[(CB2-selective)-415.2(a)-1(go)5.1(nist,)-416.6(G)1(W8421)4.7(66.)]TJ
8.2191 0 0 7.3052 472.5353 366.3495 Tm
.0245 Tc
(37)Tj
10.959 0 0 10.959 485.3479 361.4739 Tm
.0167 Tc
[(One)-415.7(s)-2.1(tudy)-415.1(ex-)]TJ
-15.7213 -1.1795 TD
.0178 Tc
[(amined)-295.1(a)-295.3(p)5(lant-ba)4.7(s)-1(ed)-295.1(ca)4.7(nnabis)-295.9(o).5(il)-290.9(extract)-295.8(i)3.6(n)-294.8(c)-.7(apsule)]TJ
0 -1.1847 TD
(form.)Tj
8.2191 0 0 7.3052 337.9464 340.4409 Tm
.0245 Tc
(33)Tj
10.959 0 0 10.959 349.0582 335.5653 Tm
.0168 Tc
[(Finally,)-261.8(one)-260.4(s)-2(tudy)-259.8(analyzed)-265(the)-265.6(e)3.4(ffects)-265.8(o)4.7(f)-266.4(l)3(ev-)]TJ
-3.285 -1.1795 TD
.0161 Tc
[(onantr)-2.7(adol)-2.9(,)-536.7(a)-540.2(s)-2.7(y)-1.8(ntheti)-3.3(c)-540.5(l)2.3(i)-3.3(q)3.6(ui)-3.3(d)-539.9(T)-1(HC,)-536.7(a)-2.1(dmini)-3.3(s)-2.7(ter)-2.7(e)2.7(d)]TJ
0 -1.1847 TD
.0184 Tc
[(intr)4.8(amusc)5(u).4(la)5.3(rly)5.6(.)]TJ
8.2191 0 0 7.3052 387.4393 314.5322 Tm
.0245 Tc
(34)Tj
/F8 1 Tf
10.4607 0 0 10.4607 313.0582 283.748 Tm
0 Tc
[(Risk)-301(of)-300.7(bias)]TJ
/F7 1 Tf
10.959 0 0 10.959 313.0582 270.822 Tm
[(Reviewers)-717.5(assessed)-712.5(the)-711.6(risk)-716.4(of)-714.4(bias)-710(utilizing)-711.2(the)]TJ
T*
[(Cochrane)-536.2(risk)-540.6(of)-538.5(bias)-534.2(tool)-538(for)-536.6(all)-532.2(included)-540.4(studies)]TJ
0 -1.1795 TD
[(\(Fig.)-306.5(2\).)-299.9(Two)-299(studies)-301(were)-299.8(found)-302.6(to)-299.9(be)-299.7(at)-300.8(a)-302.8(low)-295.7(risk)-302.6(of)]TJ
0 -1.1847 TD
[(bias,)-373.1(three)-366.2(studies)-368.3(were)-372.2(found)-369.8(to)-367.1(be)-367(at)-368.1(moderate)-366.4(risk)]TJ
0 -1.1795 TD
[(of)-300.5(bias,)-300.6(and)-302.3(one)-296.7(was)-301.6(found)-297.4(to)-299.9(be)-299.7(at)-300.8(high)-299.6(risk)-297.4(of)-300.5(bias.)]TJ
1.0036 -1.1795 TD
[(Reviewers)-339.8(also)-337.2(rated)-340.7(the)-339.2(quality)-335.9(of)-341.9(evidence)-338.6(for)-340.1(in-)]TJ
-1.0036 -1.1847 TD
[(cluded)-343(trials)-345.8(utilizing)-338.7(the)-344.3(GRADE)-336.8(approach.)-345.6(The)-337.6(evi-)]TJ
0 -1.1795 TD
[(dence)-479.4(for)-474.6(pain)-476.8(reduction)-475.5(in)-476.8(the)-473.7(included)-478.3(trials)-475.1(was)]TJ
0 -1.1847 TD
[(downgraded)-484.1(to)-481()47.3(low)42()-480.4(given)-484.6(the)-478.9(serious)-481.5(risk)-483.6(of)-481.6(bias)]TJ
0 -1.1795 TD
[(and)-302.3(inconsistency)-301.2(noted)-297.3(\(Table)-300.8(3\).)]TJ
/F8 1 Tf
10.4607 0 0 10.4607 313.0582 128.3527 Tm
[(Pain)-301(outcomes)]TJ
/F7 1 Tf
10.959 0 0 10.959 313.0582 115.3701 Tm
[(M)-10(e)-8.2(ta)-11.1(-)-8.1(a)-7.9(na)-10.1(l)-8.7(y)-7.6(si)-12.3(s)-334.4(r)0(e)-11.5(s)-8.5(u)-7.7(l)0(t)-11.9(s)-329.2(f)-9(o)-7(r)-329.2(p)-7.7(a)-7.9(i)-9(n)-328.1(s)-8.5(c)-8.2(o)-7(re)-11.5(s)-334.4(a)0(r)-11.2(e)-334.1(su)-11(mm)-15.9(ar)-11.2(i)-9(z)-8.2(ed)]TJ
T*
[(i)-9(n)-328.1(T)-6.8(a)-7.9(bl)-10.5(e)-354.8(4)-7.3(.)-356.2(W)-9.7(h)-7(e)0(n)-362.2(r)-8.5(ev)-10.6(i)-9(e)-8.2(w)-5.9(i)0(n)-11.2(g)-354.2(a)-7.9(l)-8.7(l)-355.3(1)-7.3(1)-353.9(c)-8.2(o)-7(m)0(p)-13(a)-7.9(r)-8.5(i)0(s)-12.3(o)-7(n)-7.4(s)-355.1(\()-8.8(6)-7.3(78)]TJ
T*
[(p)-7.7(a)-7.9(r)-8.5(t)-8.4(ic)-12(i)-9(p)-7.7(an)-10.1(t)-8.4(s)-8.5(\))-365.7(o)-7(f)-366(t)-8.4(h)-7(e)-365.1(i)-9(n)-7.4(cl)-11.7(u)-7.7(d)-7.7(e)-8.2(d)-364.6(s)-8.5(t)-8.4(u)0(d)-10.2(i)-9(e)-8.2(s)-365.4(\()-8.8(6)-7.3(\),)-375.4(th)-10.2(e)-8.2(r)-8.5(e)-365.1(w)-5.9(a)-7.9(s)-365.4(a)]TJ
0 -1.1847 TD
[(s)-8.5(t)-8.4(a)-7.9(t)0(i)-12.2(s)-8.5(ti)-12.2(c)-8.2(a)-7.9(ll)-12.1(y)-354.2(s)-8.5(i)-9(g)-7.6(n)-7.4(i)0()-10.8(c)-8.2(a)-7.9(n)-7.4(t)-355(t)-8.4(r)-8.5(e)0(a)-10.9(t)-8.4(me)-13.6(n)-7.4(t)-355(e)-8.2(f)-9(fe)-12.1(c)-8.2(t)-355(f)-9(o)-7(r)-355.1(t)-8.4(h)-7(e)-360(us)-11(e)-360(o)-7(f)]TJ
0 -1.1795 TD
[(cannabi)7.4(noids)-334.4(\()]TJ
/F4 1 Tf
5.8509 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
[(0.90,)-330.8(95%)-335.4(CI)]TJ
/F4 1 Tf
5.437 0 TD
()Tj
/F7 1 Tf
.6311 0 TD
[(1.69)-336.7(to)]TJ
/F4 1 Tf
2.9901 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
(0.10,)Tj
/F9 1 Tf
2.2038 0 TD
(i)Tj
/F7 1 Tf
8.2191 0 0 7.3052 517.4928 68.485 Tm
(2)Tj
/F6 1 Tf
10.959 0 0 10.959 523.2755 63.6094 Tm
(=)Tj
/F7 1 Tf
.7139 0 TD
(65%,)Tj
/F3 1 Tf
9.9626 0 0 9.9626 62.022 754.3557 Tm
(292)Tj
40.8126 0 TD
[(GAZE)-10.5(NDAM)-307.6(ET)-299.4(AL.)]TJ
ET
endstream
endobj
46 0 obj
<>stream
/GS1 gs
BT
/F9 1 Tf
10.959 0 0 10.959 59.7543 322.696 Tm
0 0 0 rg
0 Tc
0 Tw
(p)Tj
/F6 1 Tf
.6466 0 TD
(=)Tj
/F7 1 Tf
.7139 0 TD
[(0.002\).)-383.1(There)-380.1(was)-379.2(signica)7.9(nt)-383(heteroge)9.4(neity)-382(within)]TJ
-1.3605 -1.1847 TD
[(this)-229.5(analysis)-225.7(due)-230.5(to)-232.6(one)-229.5(study)-231.2(with)-226.9(a)-230.3(large)-232.2(treatm)10.2(ent)-230.9(ef-)]TJ
0 -1.1795 TD
[(fect,)-317.7(which)-311.3(utilize)8.1(d)-318.1(a)-318.3(differen)5.4(t)-318.8(route)-313.9(of)-316.1(adminis)7.3(tration)]TJ
0 -1.1847 TD
[(\(intramus)6.2(cular)-335.8(vs.)-336.1(oral\))-335.7(when)-338.8(compare)9.3(d)-338.7(with)-335.5(the)-339.2(rest)]TJ
0 -1.1795 TD
[(of)-300.5(the)-297.8(clini)9.5(cal)-298.9(trials)-294(includ)8.3(ed.)]TJ
8.2191 0 0 7.3052 187.7669 275.7543 Tm
(34)Tj
10.959 0 0 10.959 70.7527 257.896 Tm
[(Gi)11(ve)10.1(n)-467.8(t)0(h)10.5(i)0(s)-462.4(m)0(a)12.6(r)0(k)9.8(e)0(d)-465.9(d)0(i)9.2(f)0(f)12.9(e)0(r)9.2(e)0(n)10.3(c)0(e)9.5(,)-470(we)-459(str)10.9(at)14.8(i)9.8(ed)-465.9(re)9.2(su)9.7(lt)14(s)]TJ
-1.0036 -1.1795 TD
[(ba)11(se)9.2(d)-173.2(o)0(n)-164.4(r)0(o)10.4(u)0(t)9.8(e)-168.6(of)-166(ad)10.3(mi)11.5(ni)9.5(str)16(ati)16.1(on.)-163.6(Th)12.1(er)9.2(e)-168.6(wer)13.7(e)-168.6()0(v)11.3(e)-173.7(stu)16.9(di)9.2(es)]TJ
T*
[(\(7)-264.4(co)10.7(m)10.2(par)12.2(iso)16.9(ns)-259(and)-255.7(62)11.3(2)-265.9(p)0(a)10.3(tie)15.8(nt)10.1(s\))-260.4(th)10.5(at)-259.4(re)9.2(po)11.2(rte)11.1(d)-266.3(o)0(n)-257.5(o)0(r)10.4(a)0(l)]TJ
22.912 8.2719 TD
[(ca)9.8(nn)11.1(ab)11(in)9.5(oid)17.7(s)-277.5(a)0(n)10.6(d)-276.7(fo)9.8(un)10.8(d)-276.7(n)0(o)-273(sig)16.3(ni)9.5(c)10.6(an)10.6(t)-277.4(tre)16.3(atm)14.6(en)10.3(t)-277.4(eff)15.1(ec)9.5(t)]TJ
0 -1.1847 TD
[(wh)13(en)-310.4(com)15.7(pa)10.3(re)9.2(d)-318.1(w)0(i)11(t)0(h)-315.4(p)0(l)14.7(a)0(c)9.8(e)0(b)10.7(o)-317.4(\()]TJ
/F4 1 Tf
12.3277 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
[(0.2)17.2(1,)-342.8(95)11.3(%)-346.7(C)0(I)]TJ
/F4 1 Tf
5.437 0 TD
()Tj
/F7 1 Tf
.6311 0 TD
[(0.6)12(4)-343.5(t)0(o)]TJ
-19.0321 -1.1795 TD
[(0.2)17.2(2,)]TJ
/F9 1 Tf
2.1727 0 TD
(i)Tj
/F7 1 Tf
8.2191 0 0 7.3052 337.5495 301.6629 Tm
(2)Tj
/F6 1 Tf
10.959 0 0 10.959 343.2755 296.7873 Tm
(=)Tj
/F7 1 Tf
.7087 0 TD
(3%,)Tj
/F9 1 Tf
1.7589 0 TD
(p)Tj
/F6 1 Tf
.6363 0 TD
(=)Tj
/F7 1 Tf
.7139 0 TD
[(0.4)12(1.)-311.8(Th)12.1(er)9.2(e)-318.6(was)-311.9(on)11.5(e)-318.6(tri)15.5(al)-316.6(\(4)-310.9(co)10.7(mpa)15.3(ri-)]TJ
-6.7769 -1.1847 TD
[(so)10.4(ns)10(,)-299.3(5)0(6)-293.9(p)0(a)10.3(r)0(t)14.2(ici)10(pa)10.3(nt)10.1(s\))-291.4(th)10.5(at)-295.6(ev)10.1(alu)17.2(ate)16.9(d)-302.5(i)0(n)9.5(t)0(r)14.2(amu)15.3(sc)9.2(ul)9.5(ar)-295.7(ad)10.3(-)]TJ
0 -1.1795 TD
[(mi)11.5(ni)9.5(str)16.1(ati)16.1(on)-417.8(of)-419.5(ca)9.8(nn)11.1(ab)11(in)9.5(oid)12.6(s)-422.3(a)0(n)10.6(d)-426.7(fo)9.8(un)10.8(d)-421.5(a)-426.9(si)13.6(gn)10.9(i)9.8(ca)9.8(nt)]TJ
0 -1.1847 TD
[(tre)16.3(atm)14.6(en)10.3(t)-324(eff)15.1(ec)9.5(t)-329.1(fav)16.9(or)10.4(in)9.5(g)-328.3(t)0(h)10.5(e)-323.8(us)9.7(e)-328.9(o)0(f)-321.2(c)0(a)9.8(n)0(n)11.2(a)0(b)11(i)0(n)9.5(oid)12.6(s)-324(o)0(v)11.3(e)0(r)]TJ
0 -1.1795 TD
[(pl)9.5(ac)9.8(eb)10.7(o)-674.3(\()]TJ
/F4 1 Tf
3.8851 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
[(2.9)17.2(8,)-673.9(95)11.3(%)-677.8(C)0(I)]TJ
/F4 1 Tf
6.4303 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
[(4.)14.1(09)-676.7(to)]TJ
/F4 1 Tf
3.6523 0 TD
()Tj
/F7 1 Tf
.6363 0 TD
[(1.8)17.2(7,)]TJ
/F9 1 Tf
2.5297 0 TD
(i)Tj
/F7 1 Tf
8.2191 0 0 7.3052 515.5085 249.8456 Tm
(2)Tj
/F6 1 Tf
10.959 0 0 10.959 521.1779 244.97 Tm
(=)Tj
/F7 1 Tf
.7139 0 TD
[(39)11.3(%,)]TJ
/F9 1 Tf
-19.9064 -1.1795 TD
(p)Tj
/F6 1 Tf
.6363 0 TD
(<)Tj
/F7 1 Tf
.7139 0 TD
[(0.0)12(00)11.3(1\))9.8(.)]TJ
ET
59.754 191.339 490.167 .22675 re
f
59.754 75.798 490.167 .22675 re
f
59.754 164.296 490.167 .22676 re
f
BT
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 198.0283 Tm
[(Table)-306.5(1.)-500.5(Studies)-301.8(Included)-307.8(in)-297.8(the)-303.4(Meta-Analysis)]TJ
/F1 1 Tf
7.9702 0 0 7.9702 59.7543 170.6456 Tm
(Study)Tj
10.3354 1.1239 TD
[(Total)-328.8(no.)-332.8(of)]TJ
-.9389 -1.1239 TD
[(patients)-327(\(males\))-6558.7(Pain)-334(stimulus)]TJ
27.9048 1.1239 TD
[(Type)-326.8(and)-329.2(dosage)]TJ
-.7042 -1.1239 TD
[(of)-335.2(cannabino)11.1(id)-330.3(used)]TJ
13.5861 1.1239 TD
[(Route)-334.7(of)]TJ
-1.2733 -1.1239 TD
[(administrat)10.7(ion)]TJ
8.3508 1.1239 TD
[(Length)-333.6(of)]TJ
.0569 -1.1239 TD
(follow-up)Tj
/F8 1 Tf
-57.3176 -2.1411 TD
(Beaulieu)Tj
5.9774 0 0 5.3127 88.1008 157.1527 Tm
(32)Tj
7.9702 0 0 7.9702 150.633 153.5811 Tm
[(30)-331.5(\(3\))-4561.6(Surgery)-327(\(gynecologic)-323.1([46%],)]TJ
8.2086 -1.1239 TD
[(orthopedic)-330.1([44%],)-325.1(other)-330.9([10%]\))]TJ
15.6773 1.1239 TD
[(Nabilone)-320.7(\(1)-332.9(or)-332(2)-165.7(mg\))-5198.2(Oral)-6797.4(24)-167.9(h)]TJ
-35.2883 -2.2478 TD
[(Buggy)-298(et)-294.8(al.)]TJ
5.9774 0 0 5.3127 99.3826 139.1811 Tm
(33)Tj
7.9702 0 0 7.9702 150.633 135.6661 Tm
[(40)-331.5(\(0\))-4561.6(Surgery)-327(\(elective)-325.7(total)-333.4(abdomina)11.8(l)]TJ
8.2086 -1.1239 TD
[(hysterectomy)7.9(\))]TJ
15.6773 1.1239 TD
[(THC)-328.4(\(5)-162.2(mg\))-9274(Oral)-6797.4(6)-165.7(h)]TJ
-35.2883 -2.2549 TD
[(Jain)-296.6(et)-301.9(al.)]TJ
5.9774 0 0 5.3127 91.2189 121.2661 Tm
(34)Tj
7.9702 0 0 7.9702 150.633 117.6945 Tm
[(56)-331.5(\(51\))-4051.6(Acute)-331.7(postoperati)9.2(ve,)-332(trauma,)]TJ
8.2086 -1.1239 TD
[(or)-332(fracture)-332.6(pain)]TJ
15.6773 1.1239 TD
[(Levonan)14.4(tradol)]TJ
1.2235 -1.1239 TD
[(\(1.5,)-332.3(2,)-331.5(2.5,)-328.7(or)-332(3)-165.7(mg\))]TJ
12.7041 1.1239 TD
[(Intramuscu)9(lar)-2832.4(6)-165.7(h)]TJ
-49.2158 -2.2478 TD
[(Kalliomaki)-295.4(et)-294.8(al.)]TJ
5.9774 0 0 5.3127 112.1385 103.3512 Tm
(35)Tj
7.9702 0 0 7.9702 146.5511 99.7795 Tm
[(120)-333.6(\(120\))-3541.6(Lower)-327.9(third)-331.9(molar)-327.5(surgical)-327(removal)-2058.6(AZD194)13(0)-336.5(\(800)]TJ
/F11 1 Tf
30.5438 0 TD
(l)Tj
/F8 1 Tf
.5548 0 TD
[(g\))-6393.9(Oral)-6797.4(8)-165.7(h)]TJ
-41.9888 -1.1239 TD
[(Levin)-297.2(et)-301.9(al.)]TJ
5.9774 0 0 5.3127 96.0378 94.337 Tm
(36)Tj
7.9702 0 0 7.9702 146.5511 90.822 Tm
[(340)-333.6(\(0\))-4561.6(Elective)-326(surgery)-10279.8(Nabilone)-320.7(\(0.5)-166.5(mg\))-6528.3(Oral)-6797.4(120)-162.9(min)]TJ
-10.8902 -1.1239 TD
[(Ostenfeld)-293.9(et)-301.9(al.)]TJ
5.9774 0 0 5.3127 110.4378 85.3795 Tm
(37)Tj
7.9702 0 0 7.9702 150.633 81.8646 Tm
[(92)-331.5(\(49\))-4051.6(Third)-328.5(molar)-334.6(tooth)-325.4(extraction)-4904.4(GW84216)11.9(6)-336.5(\(100)-322.9(or)-339.1(800)-162.9(mg\))-2360(Oral)-6797.4(10)-167.9(h)]TJ
-10.2714 -2.2478 TD
(THC,)Tj
/F10 1 Tf
2.198 0 TD
(D)Tj
/F8 1 Tf
5.9774 0 0 5.3127 91.559 67.5212 Tm
(9)Tj
7.9702 0 0 7.9702 94.6204 63.9496 Tm
[(-tetrahydroc)10.4(annabinol.)]TJ
ET
1 i
q 1 0 0 1 59.754 699.364 cm 0 0 m
.113 1.02 l
.602 3.474 2.462 5.394 4.932 5.896 c
6.009 5.953 l
6.009 4.989 l
5.159 4.876 l
3.116 4.586 1.44 2.856 1.077 .85 c
1.02 0 l
f*
Q
q 1 0 0 1 543.968 705.316 cm 0 0 m
1.02 -.057 l
3.505 -.503 5.415 -2.482 5.896 -4.932 c
5.953 -5.953 l
4.989 -5.953 l
4.876 -5.102 l
4.573 -3.084 2.869 -1.38 .85 -1.077 c
0 -.964 l
f*
Q
65.764 704.353 478.205 .96381 re
f
q 1 0 0 1 65.764 356.031 cm 0 0 m
-1.02 .113 l
-3.474 .397 -5.449 2.568 -5.896 4.932 c
-6.009 5.953 l
-4.989 5.953 l
-4.932 5.102 l
-4.532 3.106 -2.916 1.363 -.85 1.077 c
0 1.02 l
f*
Q
q 1 0 0 1 549.921 361.984 cm 0 0 m
-.057 -1.02 l
-.504 -3.385 -2.479 -5.556 -4.932 -5.839 c
-5.953 -5.953 l
-5.953 -4.932 l
-5.102 -4.876 l
-3.084 -4.573 -1.38 -2.869 -1.077 -.85 c
-.964 0 l
f*
Q
65.764 356.031 478.205 1.0205 re
f
59.754 361.984 1.0205 337.379 re
f
548.957 361.984 .96381 337.379 re
f
q
454.483 0 0 302.003 77.726 393.335 cm
/Im1 Do
Q
BT
/F3 1 Tf
9.9626 0 0 9.9626 110.7212 375.4204 Tm
[(FI)-7.1(G.)-336.3(1.)]TJ
/F8 1 Tf
3.8753 0 TD
[(Preferred)-309.7(Report)-10.3(ing)-300.2(Ite)-7.4(ms)-302.7(for)-302.8(Systemat)-10.3(ic)-302.8(Review)-8.1(s)-299.2(and)-307.6(Meta-Anal)-10.2(yses)-302(ow)-304.1(diagra)-11.7(m.)]TJ
/F3 1 Tf
-8.9911 37.9844 TD
[(CA)-8.2(NNABI)-9.1(NOIDS)-304.1(IN)-301(AC)-8.2(UTE)-299.6(PAI)-10(N)]TJ
47.5445 0 TD
(293)Tj
ET
endstream
endobj
48 0 obj
<>stream
Adobe d
v
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz m !1AQa"q2#BRbr3$4CS%cs5DT
&6E'dtU7()euFVfvGWgw8HXhx9IYiy*:JZjz ? g4¶(#= SM\
f6OiھMfyhgkfĈne^W1?VdkaE͗~.(f
<>
Ā<$'9Z L!_ clkf,?o_bWC7[Y pKaEP;Vƻ Vo. k k1.3w ՛˿ x/Os|h GQ)ʲt[v!5|a,/-IICH.i*GF&Ȓ"ȇ8:w"v"<DUx%Q$3OI+ Ib͊om-$ӴX! (e4qE X<ثig,?lU{O6*ZzY pKw=o] %S͊V V. ] +O[ ? a Tb ՟ yW X<ثig,?lU{O6*ZzY pKwMo^ %S͊V V/] +O[ ? a Tb ՟ yW X<ثjkg,?lU{O6*ZzY pKwMo^ %S͊V V/] +S[ ? a Tb ՟˿ yW X<ثig,?lU5{O6*ZY pKw=o^ %S͊V V/] +O[ ? a Tb ՟ yW X<ثjkg,?lU{O6*ZzY pKw=o] %S͊V V/] +O[ ? a Tb